J06BB04 • human anti-hepatitis B immunoglobulin • Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins
Human anti-hepatitis B immunoglobulin is a plasma-derived product used to prevent hepatitis B virus (HBV) infection, particularly in individuals recently exposed to the virus or those at high risk, such as newborns of infected mothers. It provides passive immunity by supplying specific antibodies against HBV.
The medication is administered via intramuscular or intravenous injection, as directed by a doctor.
Side effects may include pain at the injection site, fever, or allergic reactions. In rare cases, anaphylactic reactions may occur.
Patients should inform their doctor about any known allergies or other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
Substance: human anti-hepatitis B immunoglobulin
Date of last drug list: 10-04-2026
Commercial code: W54188003
Concentration: 50UI / ml
Pharmaceutical form: solution for infusion
Packing volume: 40ml
Product type: original
Price: 4252.07 RON
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: BIOTEST PHARMA GMBH - GERMANIA
Holder: BIOTEST PHARMA GMBH - GERMANIA
Number: 7349/2015/03
Shelf life: 2 years
NHP 9.8 (C2) - Treatment of chronic HBV hepatitis recurrence in liver transplant patients
Price
Copayment
Patient
4252.07 RON
4252.07 RON
0.00 RON